Patel Amar R, Mishra Kunal, Ortega Andrew J, Patel Avani R, Segovia Fernando D, Montanez Ruben, Makhija Rakhee, Roongsritong Chanwit, Borges Jorge C
Internal Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, USA.
Vascular Medicine, University of Virginia, Charlottesville, USA.
Cureus. 2023 Mar 28;15(3):e36814. doi: 10.7759/cureus.36814. eCollection 2023 Mar.
The coronavirus disease of 2019 (COVID-19) has an array of pathological effects that continue to be discovered. Vaccines against COVID-19 have quickly emerged as our main tool. However, the thrombotic risk of both the virus and the vaccine is yet to be established, let alone together. In this case report, we present a case involving a recently diagnosed COVID-19 patient who developed an ST-elevated myocardial infarction (STEMI) after receiving his booster shot. Our aim is to highlight the standard of treatment outcomes in COVID-19-associated clots, familiarize ourselves with the complexity of the clot burden in a COVID-19-associated STEMI, and illustrate the potential role of the cumulative pro-thrombotic effects of a recent COVID-19 booster with a concomitant symptomatic COVID-19 infection.
2019年冠状病毒病（COVID-19）具有一系列仍在不断被发现的病理效应。针对COVID-19的疫苗已迅速成为我们的主要工具。然而，病毒和疫苗的血栓形成风险尚未明确，更不用说两者共同作用的情况了。在本病例报告中，我们呈现了一例涉及近期确诊的COVID-19患者的病例，该患者在接种加强针后发生了ST段抬高型心肌梗死（STEMI）。我们的目的是强调COVID-19相关血栓的治疗结果标准，熟悉COVID-19相关STEMI中血栓负荷的复杂性，并说明近期COVID-19加强针与同时出现症状的COVID-19感染的累积促血栓形成效应的潜在作用。
